Close
  • 00 atmail

Items tagged with: Michael Panaccio

Team Members
    Portfolio Items
    • Armaron Bio

      Armaron Bio is a life sciences start-up company based in Melbourne. Armaron Bio is developing proprietary lead cardioprotectant and neuroprotectant small molecules to reduce tissue damage following a heart attack or stroke. Its lead compound is presently in Phase I clinical development and will enter a Proof of Concept Phase II trial in 2015.

    • dorsaVi

      dorsaVi Pty Ltd (previously Pro-Active Medical Pty Ltd) is a biotechnology company focused on developing innovative motion analysis device technologies. 

      dorsaVi has three distinct products: ViMove for the clinical market, ViSafe for the work safety market and ViPerform for the sport market.

      dorsaVi listed on the ASX in December 2013 - DVL.ASX .

    • Energy Response

      Energy Response focuses on implementing energy management solutions to make the electricity industry more efficient, striving to save energy at times of peak demand or during a grid emergency. 

      Demand Response (DR) is a way to reduce the need to raise electricity prices, as approximately half of the rate rises are due to network infrastructure investment aimed at supporting peak demand.

      Energy Response was acquired by EnerNOC in in 2011.

    • Finisar

      Finisar Corporation is a global technology leader in optical communications components and subsystems. These products enable high-speed voice, video and data communications for networking, storage, wireless, and cable TV applications.

      Over the past two decades, Finisar has provided critical breakthroughs in optics technologies and has supplied system manufacturers with the production volumes needed to meet the exploding demand for network bandwidth and storage. Finisar's industry-leading optical products include transceivers/transponders, active cables, WSS ROADMs, optical instruments, and active and passive components.

      Finisar was listed on the NASDAQ in November 1999 (FNSR). 

    • ImpediMed

      ImpediMed is a medical device company that designs, develops and markets proprietary bioimpedance analysis systems for use in non-invasive screening and monitoring of human disorders and diseases. ImpediMed markets products in three core areas, body composition for medical applications, hydration status monitoring and the detection and monitoring of lymphoedema and oedema.

      Impedimed was listed on the Australian Stock Exchange in October 2007 (ASX:IPD). 

    • Monitoring Division

      Monitoring Division Inc. is a revolutionary network performance monitoring company.The company’s tools let optical network operators, system vendors and high tech optical labs cost-effectively characterize fiber assets and transmission equipment in order to perform network upgrades, troubleshoot and maintain current systems and continuously manage high-speed networks.

    • MuriGen Therapeutics

      MuriGen Therapeutics is a drug discovery and development company established by the Walter and Eliza Hall Institute of Medical Research (WEHI).

      MuriGen is building a portfolio of novel drugs for unmet medical needs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammation, epilepsy and thalassemia.

    • NephroDynamics

      Nephrodynamics focused on drugs treating kidney failure during and after septic shock. 

       

    • Ofidium

      Ofidium’s unique 100 Gigabits per second optical OFDM technology delivers increased bandwidth and reduced costs for telecommunications networks. By enabling 100 Gbit/s transmission over existing telecommunications infrastructure, Ofidium’s optical OFDM technology provides highly efficient capacity growth for new optical fiber and dramatic performance improvements for current networks.

    News Articles